FGFR2 and colorectal carcinoma: In addition, PD-L1 expression in CRC specimens is positively correlated with FGFR2 expression, which promotes PD-L1 expression in CRC by activating the JAK/STAT3 signaling pathway, which further promotes T cell apoptosis and leads to tumor immunosuppression.